DCOY
Decoy TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
Documents
1
Stored
Transcripts
0
Recent loaded
Latest report
2026-05-09
Investor release
Document history
Earnings documents stored for DCOY.
Investor releaseQuarter not tagged2026-05-09Decoy Therapeutics: Q1 Earnings Snapshot
Associated Press
Investor releaseQuarter not tagged2026-05-09
Decoy Therapeutics: Q1 Earnings Snapshot
Associated Press
HOUSTON (AP) — HOUSTON (AP) — Decoy Therapeutics Inc. (DCOY) on Friday reported a loss of $2.2 million in its first quarter. The Houston-based company said it had a loss of $4.18 per share. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DCOY at https://www.zacks.com/ap/DCOY
As of 2026-05-18 • Updated weeklySource: Earnings sourceIngestion runbook